News in brief

Friend stake mate’s house A row has developed between two friends in Nyamagabe district.The row developed after one Ignace Nsanzebahire used his friend Celestine Nteziryayo’s house as a guarantee to get a loan from Bank Populaire.

Tuesday, August 18, 2009

Friend stake mate’s house

A row has developed between two friends in Nyamagabe district.

The row developed after one Ignace Nsanzebahire used his friend Celestine Nteziryayo’s house as a guarantee to get a loan from Bank Populaire.

The bank has put the house up for sale for Rwf7m after Nsanzebahire failed to pay up.

And Nteziryayo has now accused the Bank of conniving with Nsanzebahire to sale off his house. Nteziryayo values his house at Rwf30m.

Catholics hold pilgrimage

Over twenty thousand Catholics from across the country are attending this year’s 15th pilgrimage to remember Mary’s the mother of Jesus.

According to Fr. Museminali Habiyambere, this year has registered an increase in the numbers of people who turned up, adding that Kibeho has continued to be a favourite destination for the faithful seeking Gods blessing.

USAID trains parties on media

The United States Agency for International Development (USAID) has held media training for political parties ahead of the 2010 presidential polls.

The training was held to equip the political parties on how deal with the media during the elections. 

Kamonyi mayor resigns

The mayor of Kamonyi district Jean Paul Munyandamutsa has resigned from his post.

The mayor, who is currently out of the country, communicated his resignation through an e-mail.

Munyandamutsa is rumored to have resigned citing misunderstanding with his fellow colleagues in the district.

New ARVs in offing

Rwandans diagnosed with HIV/AIDS will soon upgrade to first choice Anti Retroviral therapy (ART) drug treatment as the Government moves to the use of the first choice drugs expected to begin this month, disease control officials have said.

Tenofovir (TDF), used by roughly two percent of Rwandan adults fighting HIV, will replace the out-dated drug recommendation.

It will be one of three ARV drugs combined to make the premier option for first line therapy for adults.

Dr. Sabin Nsanzimana, the Care and Treatment Department Coordinator said the national guideline is the main tool used to determine which treatment a patient will be starting and the patient’s treatment is then reviewed and changed accordingly.

Ends